CTI BioPharma Corp.

CTI BioPharma Corp. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. CTI BioPharma Corp. is not very popular among insiders. CTI BioPharma Corp. is a mediocre stock to choose.
Log in to see more information.
CTI BioPharma Corp. operates as a biopharmaceutical company, which focuses on the development, acqui...
CTIC Fundamental Data by TradingView

News

StockNews.com Initiates Coverage on CTI BioPharma (NASDAQ:CTIC)
StockNews.com Initiates Coverage on CTI BioPharma (NASDAQ:CTIC)

Zolmax Research analysts at StockNews.com assumed coverage on shares of CTI BioPharma (NASDAQ:CTIC Free Report) in a research note issued on Tuesday. The brokerage set a hold rating on the biopharmaceutical companys stock. CTIC has been the subject of several other research reports. Needham & Company LLC ...\n more…

CTI BioPharma (NASDAQ:CTIC) Now Covered by Analysts at StockNews.com
CTI BioPharma (NASDAQ:CTIC) Now Covered by Analysts at StockNews.com

Ticker Report StockNews.com started coverage on shares of CTI BioPharma (NASDAQ:CTIC Get Rating) in a research note released on Tuesday . The firm issued a hold rating on the biopharmaceutical companys stock. A number of other equities analysts have also recently commented on CTIC. Stifel Nicolaus ...\n more…

DRI Healthcare Trust says CTI BioPharma repaid $54.8M debt
DRI Healthcare Trust says CTI BioPharma repaid $54.8M debt

SeekingAlpha.com: All News DRI Healthcare Trust (TSX: DHT.UN) said Monday that CTI BioPharma has prepaid all amounts outstanding under the credit facility it entered with DRI's unit\n more…

Sobi completes acquisition of CTI BioPharma Corp.
Sobi completes acquisition of CTI BioPharma Corp.

PR Newswire Sobi completes acquisition of CTI BioPharma Corp. Sobi completes acquisition of CTI BioPharma Corp. PR Newswire STOCKHOLM, June 26, 2023 STOCKHOLM, June 26, 2023 /PRNewswire/ -- Swedish OrphanBiovitrum AB (publ) (Sobi) (STO:SOBI) and CTI BioPharma Corp. (NASDAQ:CTIC) (CTI) announced today the...\n more…

Sobi successfully completes tender offer for all outstanding shares of common stock of CTI BioPharma Corp.
Sobi successfully completes tender offer for all outstanding shares of common stock of CTI BioPharma Corp.

PR Newswire Sobi successfully completes tender offer for all outstanding shares of common stock of CTI BioPharma Corp. Sobi successfully completes tender offer for all outstanding shares of common stock of CTI BioPharma Corp. PR Newswire STOCKHOLM, June 24, 2023 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN...\n more…

StockNews.com Initiates Coverage on CTI BioPharma (NASDAQ:CTIC)
StockNews.com Initiates Coverage on CTI BioPharma (NASDAQ:CTIC)

Ticker Report Equities research analysts at StockNews.com began coverage on shares of CTI BioPharma (NASDAQ:CTIC Get Rating) in a research report issued on Monday. The firm set a hold rating on the biopharmaceutical companys stock. A number of other research firms have also recently ...\n more…